- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GBP2 antibody (AB247040)
Paraffin-embedded human urinary bladder tissue stained for GBP2 using ab247040 at 1/50 dilution in immunohistochemical analysis.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-GBP2 antibody (AB247040)
PFA fixed, Triton X-100 permeabilized RT4 (Human urinary bladder cancer cell line) cells labeling GBP2 using ab247040 at 4 μg/ml (green) in ICC/IF.
- WB
Unknown
Western blot - Anti-GBP2 antibody (AB247040)
All lanes:
Western blot - Anti-GBP2 antibody (ab247040) at 0.4 µg/mL
All lanes:
RT4 (Human urinary bladder cancer cell line) cell lysate
Predicted band size: 67 kDa
false
Reactivity 정보
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 기간
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Guanylate Binding Protein 2 participates in immune response regulation. It does not function as part of a large multiprotein complex but acts primarily as a monomer. GBP2 disrupts pathogenic molecular machinery by binding to microbial enzymes leading to their inhibition which limits pathogen survival. This mechanism ensures that GBP2 remains a significant factor in the cell's intrinsic ability to fight infections at the molecular level.
Pathways
Guanylate Binding Protein 2 plays an important role in the interferon-induced defense pathways. It participates in the immune effector pathways primarily connecting to processes like the JAK-STAT signaling pathway. Through this involvement GBP2 helps enhance the expression of a variety of immunologically relevant genes. Additionally GBP2 often interacts with other members of the GBP family including GBP1 and GBP5 to amplify immune responses and signaling cascades.
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
대체 명칭 보기
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com